Registry of biomedical companies:
[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 460 active entries
161# Jieguan Road, Tianmen economy development zon
431700
China
Phone: 0086-728-5332568
E-Mail:
This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Stock symbol: Hubei Teye
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Description:
Hubei Teyer Pharmaceutical Co., Ltd. was established in 2002, and is located in Tianmen, a historic city in Hubei Province, the former residence of Chinese "Tea Saint" Lu Yu.
Our company is committed to the production and distribution of Ganciclovir and other APIs advanced intermediates for about 20 years.
Teyer Pharmaceutical has developed a new synthesis process for Ganciclovir. , and we developed the groundbreaking research of synthesis process on Valganciclovir hydrochloride and obtained the invention patent certificate in 2017.
We are the first domestic manufacturer that successfully develop and produce the Monoacetylganciclovir, and our product lines also including the production of Diacetyl ganciclovir, Benzyl ganciclovir, CBZ-valganciclovir. Hubei Teyer Pharmaceutical Co., Ltd is a high-tech enterprise in Hubei Province. Our factory covers an area of 16,000 square meters. We own two GMP raw material synthesis workshops and a capsule tablet workshop, every workshop is strictly equipped with an independent clean and refining area.
We earnestly abide by the "Pharmaceutical Administration Law of the People's Republic of China" and organize production strictly conform to the "Pharmaceutical Production Quality Management Regulations".
Relying on the concept of "Being authentic, Being driven "
and adhering to the inner core of "Life is to gain the true knowledge",
Teyer Pharmaceutical is defining ourselves in terms of customers and markers，we are acting entrepreneurially by seizing the moment.
There is a huge potential development of Teyer Pharmaceutical,
Our exclusive API production technology will help our partners to obtain excess profits and ensure the production market advantage when they apply it to the tablet or injection production.
After years of development, Teyer Pharmaceutical Co., Ltd. has become a special enterprise in China relying on its scientific management and strict production level.We will never forget the original intention and keep struggling to provide the best quality products and service to all of our customers.
Our belief is "to establish an image of integrity, to create a quality brand, to be market-oriented, and to seek development through innovation". Sodium lauryl sulfoacetate SLSA exclusive supplier！
Selected Categories:
Last update of this entry: September 28, 2021
|